Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rivaroxaban”

431 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 431 results

Not applicableLooking for participantsNCT03504007
What this trial is testing

Registry of Patients Prescribed Anticoagulation

Who this might be right for
Acute Deep Vein ThrombosisAcute Pulmonary Embolism
Mayo Clinic 10,000
Not applicableStudy completedNCT02090543
What this trial is testing

BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies

Who this might be right for
Atrial Fibrillation
Bayer 647
Large-scale testing (Phase 3)Study completedNCT01720108
What this trial is testing

Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
David Anderson 3,426
Early research (Phase 1)Looking for participantsNCT06831474
What this trial is testing

Excretion of Rivaroxaban in Human Breast Milk

Who this might be right for
PostpartumVTE ProphylaxisVTE (Venous Thromboembolism)+3 more
Thomas Jefferson University 10
Not applicableStudy completedNCT02876718
What this trial is testing

Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study

Who this might be right for
Atrial Fibrillation
Bayer 253
Early research (Phase 1)Study completedNCT05418803
What this trial is testing

BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects

Who this might be right for
Healthy Volunteer
Yuhan Corporation 34
Not applicableUnknownNCT02147444
What this trial is testing

Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Tohoku University 7,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT06925698
What this trial is testing

Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease

Who this might be right for
Behcet DiseaseBehcet Disease and Vascular InvolvementDeep Venous Thromboses+1 more
Marmara University 110
Post-approval studies (Phase 4)Looking for participantsNCT04642430
What this trial is testing

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Ottawa Hospital Research Institute 3,018
Not applicableWithdrawnNCT03537521
What this trial is testing

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New Antidots

Who this might be right for
Severe BleedingUrgent Surgery
Cardioangiologisches Centrum Bethanien
Early research (Phase 1)Study completedNCT02438098
What this trial is testing

Rivaroxaban in Bariatric Surgery

Who this might be right for
Prophylaxis of Venous Thromboembolism
Insel Gruppe AG, University Hospital Bern 13
Not applicableStudy completedNCT01925755
What this trial is testing

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients

Who this might be right for
StrokeEmbolism
Bayer 209
Post-approval studies (Phase 4)Active Not RecruitingNCT03129490
What this trial is testing

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationAtrial Flutter
Herlev and Gentofte Hospital 11,000
Not applicableStudy completedNCT02502396
What this trial is testing

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Who this might be right for
CancerDeep-vein Thrombosis of the Lower and Upper ExtremitiesPulmonary Embolism+1 more
M.D. Anderson Cancer Center 265
Post-approval studies (Phase 4)Looking for participantsNCT06953726
What this trial is testing

Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

Who this might be right for
Atrial Fibrillation
VA Office of Research and Development 10,000
Post-approval studies (Phase 4)Study completedNCT02047006
What this trial is testing

Dose-finding of Rivaroxaban in Hemodialysis

Who this might be right for
Chronic Renal Failure
AZ Sint-Jan AV 18
Early research (Phase 1)Study completedNCT02832947
What this trial is testing

PK of Rivaroxaban in Bariatric Patients - Extension

Who this might be right for
Prophylaxis of Venous Thromboembolism
Insel Gruppe AG, University Hospital Bern 13
Testing effectiveness (Phase 2)Study completedNCT00839826
What this trial is testing

ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial

Who this might be right for
ThromboembolismPrevention
Bayer 641
Large-scale testing (Phase 3)Study completedNCT03702582
What this trial is testing

Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation

Who this might be right for
Atrial FibrillationStrokeBleeding
Massachusetts General Hospital 100
Testing effectiveness (Phase 2)Study completedNCT03522259
What this trial is testing

Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery

Who this might be right for
Bariatric Surgery
Insel Gruppe AG, University Hospital Bern 272
Next Page